Redmile Group is a hedge fund and private equity management company that does venture investments, private equity, and post IPO equity investments in the healthcare industry. The company was founded in 2007 and is based in San Francisco, California. It focuses on biotechnology, healthcare, therapeutics, life sciences, and the medical devices sector. The firm has invested in companies like AlloVir, IGM Biosciences, Saluda Medical, Repare Therapeutics, ArcherDX, Augmedix, and BioNTech. As of January 2020, the firm has had 38 exits.
An exosome therapeutics company founded in 2016 and based in Oxford, UK, that uses exosomes to deliver small and large molecule therapeutics. The company has a proprietary technology to modify exosomes to target specific organs such as the brain and central nervous system.
A synthetic biology company using CRISPR to develop a portfolio of genetic medicines.
Augmedix is a technology-enabled service platform that helps simplify how physicians work and deal with patients by utilizing wearable technology.
TCR2 Therapeutics is a biotechnology company developing T cell hematologic cancer immunotherapies.
Cabaletta Bio is a biotechnology company developing cellular therapies for autoimmune disease.
A company providing emergency medical care
BioNTech develops immunotherapies for the treatment of cancer and other diseases.
Virtahealth is a healthcare company founded by Sami Inkinen.
Stoke Therapeutics is a Bedford, Massachusetts-based company.
Scholar Rock is a Cambridge, Massachusetts-based company.
IGM Biosciences is a Mountain View, California-based company.
Repare Therapeutics is a Saint-Laurent, Quebec-based company.
Documentaries, videos and podcasts